BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35400344)

  • 1. A Review on Exploring the Opportunities of Polymer Drug Conjugated Systems for Targeted Cancer Treatment.
    Gupta C; Naik I; Menon M; Ambre P; Coutinho E
    Curr Drug Deliv; 2022; 20(1):8-30. PubMed ID: 35400344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-Drug Conjugates for Anticancer Drug Delivery.
    Wadhwa S; Mumper RJ
    Crit Rev Ther Drug Carrier Syst; 2015; 32(3):215-45. PubMed ID: 26080809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting EPR in polymer drug conjugate delivery for tumor targeting.
    Modi S; Prakash Jain J; Domb AJ; Kumar N
    Curr Pharm Des; 2006; 12(36):4785-96. PubMed ID: 17168778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent protein-drug conjugates - An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells.
    Porębska N; Ciura K; Chorążewska A; Zakrzewska M; Otlewski J; Opaliński Ł
    Biotechnol Adv; 2023 Oct; 67():108213. PubMed ID: 37453463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable polymers for targeted delivery of anti-cancer drugs.
    Doppalapudi S; Jain A; Domb AJ; Khan W
    Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking nanoparticulate polymer-drug conjugates for cancer theranostics.
    Wang Y; Xia H; Chen B; Wang Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1828. PubMed ID: 35734967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative Design of Targeted Nanoparticles: Polymer-Drug Conjugates for Enhanced Cancer Therapy.
    Junyaprasert VB; Thummarati P
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-drug conjugates: A new paradigm for targeted cancer therapy.
    Wang M; Liu J; Xia M; Yin L; Zhang L; Liu X; Cheng Y
    Eur J Med Chem; 2024 Feb; 265():116119. PubMed ID: 38194773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Conjugates Using Different Dynamic Covalent Bonds and their Application in Cancer Therapy.
    Theodosis-Nobelos P; Charalambous D; Triantis C; Rikkou-Kalourkoti M
    Curr Drug Deliv; 2020; 17(7):542-557. PubMed ID: 32384029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
    Fu C; Yu L; Miao Y; Liu X; Yu Z; Wei M
    Acta Pharm Sin B; 2023 Feb; 13(2):498-516. PubMed ID: 36873165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineering strategies for designing targeted cancer therapies.
    Alexander-Bryant AA; Vanden Berg-Foels WS; Wen X
    Adv Cancer Res; 2013; 118():1-59. PubMed ID: 23768509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery.
    Kaur H; Desai SD; Kumar V; Rathi P; Singh J
    Anticancer Agents Med Chem; 2016; 16(11):1355-1377. PubMed ID: 27141881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecularly imprinted polymer essentials: curation of anticancer, ophthalmic, and projected gene therapy drug delivery systems.
    Tuwahatu CA; Yeung CC; Lam YW; Roy VAL
    J Control Release; 2018 Oct; 287():24-34. PubMed ID: 30110614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-targeted polymeric drugs.
    Luo Y; Prestwich GD
    Curr Cancer Drug Targets; 2002 Sep; 2(3):209-26. PubMed ID: 12188908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted polymer-drug conjugates: Current progress and future perspective.
    Xu H; Ma H; Yang P; Zhang X; Wu X; Yin W; Wang H; Xu D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():729-34. PubMed ID: 26513756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.